Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 12Completed 6Terminated 2Active not recruiting 2Recruiting 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

zilucoplan 1rozanolixizumab 1fludarabine phosphate 1fludarabine 1exemestane 1epigallocatechin gallate 1durvalumab 1aumolertinib 1atropine sulfate-diphenoxylate hydrochloride drug combination 1Vincristine 1Tamoxifen 1Sodium Chloride 1R-CHOP protocol 1Prednisone 1Pemetrexed 1Omeprazole 1Melphalan 1Loperamide 1Letrozole 1High-Energy Shock Waves 1Gastroscopy 1Etoposide 1Doxorubicin 1Dexamethasone 1Decitabine 1Cytarabine 1Cyclophosphamide 1Cisplatin 1Catechin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Enrolling by invitation × Decitabine × Clear all
NCT07348575 2026-01-16

A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma

Second Affiliated Hospital of Nanchang University

Phase 3 Enrolling by invitation
80 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡